Patrick Thompson is a seasoned professional with extensive experience in the biopharmaceutical industry, currently serving as Senior Director of Upstream CMC at Immunovant since October 2021, previously holding the position of Director Upstream CMC. Prior experience includes roles as Sr. Manager and Principal Engineer at Seqirus, where Patrick led technology transfer efforts for influenza vaccine manufacturing. At Bristol-Myers Squibb, spanning from October 2004 to December 2018, Patrick held multiple positions including Senior Engineer, overseeing technical aspects of monoclonal antibody drug substance programs and successfully managing process validation activities that facilitated commercial readiness. Patrick's educational background includes a Master’s degree in Chemical Engineering from Syracuse University and a Bachelor’s degree in Biological Sciences from the Rochester Institute of Technology.
This person is not in any teams
This person is not in any offices